Crispr News
-
For sickle cell patients, a CRISPR cure could mean infertility - STAT - STATDecember 6, 2023
-
CRISPR's Reach Widens: Enzyme Targets Nearly All Human Genes - Technology NetworksDecember 6, 2023
-
Siddhartha Mukherjee: CRISPR, AI, and cloning could transform the human race - GZERO MediaDecember 5, 2023
-
CRISPR (CRSP) to Focus on Next-Generation CAR T Pipeline - Yahoo FinanceDecember 5, 2023
-
CRISPR (CRSP) to Focus on Next-Generation CAR T Pipeline - Zacks Investment ResearchDecember 5, 2023
-
Eligo Bioscience Raises $30M in Series B Financing to Develop CRISPR-Based Acne Drug - Precision Medicine OnlineDecember 5, 2023
-
CRISPR Therapeutics ventures into autoimmune disorder CAR T development - Pharmaceutical TechnologyDecember 5, 2023
-
CRISPR Reorganizes CAR-T Pipeline Ahead of FDA’s Landmark Decision - BioSpaceDecember 5, 2023
-
First CRISPR Sickle Cell Patient ‘Reborn’: FDA Approval Expected - ForbesDecember 5, 2023
-
New enzyme allows CRISPR technologies to accurately target almost all human genes - Phys.orgDecember 5, 2023
-
Better Growth Stock: CRISPR Therapeutics vs. Invitae - The Motley FoolDecember 5, 2023
-
Viewpoint: Skeptical take on newly-approved CRISPR sickle cell treatment tool - Genetic Literacy ProjectDecember 5, 2023
-
Crispr gene editing technology could transform medicine | FT Tech - Financial TimesDecember 5, 2023
-
CRISPR Tx cuts cancer programs, expands into autoimmune disease - FierceBiotechDecember 5, 2023
-
CRISPR Therapeutics (CRSP) CTX110 and CTX130 provided important proof of concept - StreetInsider.comDecember 4, 2023
-
CRISPR Therapeutics Announces Updates to Immuno-Oncology Pipeline and Expansion into Autoimmune Disease - GlobeNewswireDecember 4, 2023
-
CRISPR Therapeutics Announces Updates to Immuno-Oncology Pipeline and Expansion into Autoimmune Disease - Yahoo FinanceDecember 4, 2023
-
New discovery unveils an additional layer of the CRISPR-Cas antiviral defense system - News-Medical.NetDecember 4, 2023
-
Pro Research: Wall Street eyes CRISPR Therapeutics' growth By Investing.com - Investing.comDecember 4, 2023
-
First approval of a CRISPR-based gene therapy – Exaudi - ExaudiDecember 4, 2023